The Porter Research survey commissioned by Invistics found that nine out of 10 surveyed believe their facility’s drug diversion program is the same or even better than other organizations, and two out of three are confident or very confident that their drug diversion program successfully identifies employees who divert drugs. But there is definitely a disconnect, because 70% of participants said they believe most diversion incidents in the U.S. go undetected.
Researchers at the University of Utah Health, Harvard University, and Brigham and Women’s Hospital in Boston found that the most commonly used EHRs in hospitals across the nation fail to detect up to 33% of potentially dangerous drug interactions and other medication errors that could harm or kill patients.
The proposal includes a name change and reorganization of drug lists so that not all antineoplastic drugs, most often associated with cancer treatments, are grouped together. Formerly the “NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings,” the list will be called more simply the “NIOSH List of Hazardous Drugs in Healthcare Settings, 2020.”
Whether used as a full decentralized drug distribution model or for limited distribution of controlled substances, PRN (as needed) medications, and first doses only, ADCs today are often interfaced with electronic health record systems in both large and small healthcare settings.
The survey found that 86% surveyed have met or know someone who has diverted drugs, with another 43% indicating their facility could be at risk of fines, bad publicity, lawsuits, or overdoses because of past or potential drug diversion cases.
So far, the network has tracked drug diversion at 90 hospitals, 28 nursing homes, and dozens of other types of healthcare facilities, including ambulatory surgical centers, assisted living centers, clinics, compounding pharmacies, medical laboratories, mental health facilities, pain clinics, rehabilitation homes, retail pharmacies, and schools.
When ISMP receives a hazard or error report, it is entered into one of our databases and initially reviewed by an ISMP nurse or pharmacy technician analyst. Since most reports submitted to ISMP include the reporter’s email address, ISMP sends an email to the reporter to confirm receipt of the report and to thank him or her for reporting.
Drug diversion costs the healthcare industry more than $70 billion per year, according to one estimate, and some researchers say as many as 10% of all medical professionals will divert drugs from their workplace at some point in their career.
Researchers NYU Grossman School of Medicine and University of California, Davis, analyzed cause-of-death data from the National Vital Statistics System from 3,109 counties nationwide between 2001 and 2017.
Healthcare providers in U.S. hospitals bear the brunt of the epidemic as they deal with the medical consequences of opioid addiction. From 1999 to 2017, Coverys says, more than 700,000 people died as a result of the opioid epidemic and the number of opioid-related overdoses grew sixfold.